AT2 receptor levels have been shown to be markedly increased in breast tumors as compared to normal tissue (De Paepe et al., 2002; Table 1) raising the question of the functional effect of AT2 over expression in breast cancer. The gene discussed is AGTR2; the disease is breast carcinoma.